ACE2 and viral infectious disease: Indeed, injection of a soluble form of recombinant human ACE2 (rhACE2, GSK2586881) into mice infected with SARS-CoV appears to have a double role [18]: it slows the viral infection by binding to the S-protein and rescues ACE2 activity, thus causing angiotensin II reduction and protecting lung from severe failure.